» Articles » PMID: 25363080

Alveolar-capillary Adaptation to Chronic Hypoxia in the Fatty Lung

Overview
Specialty Physiology
Date 2014 Nov 4
PMID 25363080
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: Obese diabetic (ZDF fa/fa) rats with genetic leptin resistance suffer chronic lipotoxicity associated with age-related lung restriction and abnormal alveolar ultrastructure. We hypothesized that these abnormalities impair adaptation to ambient hypoxia.

Methods: Male fa/fa and lean (+/+) ZDF rats (4-months old) were exposed to 21 or 13% O2 for 3 weeks. Lung function was measured under anaesthesia. Lung tissue was assayed for DNA damage and ultrastructure measured by morphometry.

Results: In normoxia, lung volume, compliance and diffusing capacity were lower, while blood flow was higher in fa/fa than +/+ rats. In hypoxia, fa/fa animals lost more weight, circulating hematocrit rose higher, and lung volume failed to increase compared to +/+. In fa/fa, the hypoxia-induced increase in post-mortem lung volume was attenuated (19%) vs. +/+ (39%). Alveolar ducts were 35% smaller in normoxia but enlarged twofold more in hypoxia compared to +/+. Hypoxia induced broad increases (90-100%) in the volumes and surface areas of alveolar septal components in +/+ lungs; these increases were moderately attenuated in fa/fa lungs (58-75%), especially that of type II epithelium volume (16 vs. 61% in +/+). In fa/fa compared to +/+ lungs, oxidative DNA damage was greater with increased hypoxia induced efflux of alveolar macrophages. Harmonic mean thickness of the diffusion barrier was higher, indicating higher structural resistance to gas transfer.

Conclusion: Chronic lipotoxicity impaired hypoxia-induced lung expansion and compensatory alveolar growth with disproportionate effect on resident alveolar progenitor cells. The moderate structural impairment was offset by physiological adaptation primarily via a higher hematocrit.

Citing Articles

The effects of genetic deletion of Macrophage migration inhibitory factor on the chronically hypoxic pulmonary circulation.

Li L, Xu M, Rowan S, Howell K, Russell-Hallinan A, Donnelly S Pulm Circ. 2021; 10(4):2045894020941352.

PMID: 33447370 PMC: 7780187. DOI: 10.1177/2045894020941352.


When Two Pandemics Meet: Why Is Obesity Associated with Increased COVID-19 Mortality?.

Lockhart S, ORahilly S Med. 2020; 1(1):33-42.

PMID: 32838359 PMC: 7323660. DOI: 10.1016/j.medj.2020.06.005.


Lipid phenotyping of lung epithelial lining fluid in healthy human volunteers.

Brandsma J, Goss V, Yang X, Bakke P, Caruso M, Chanez P Metabolomics. 2019; 14(10):123.

PMID: 30830396 PMC: 6153688. DOI: 10.1007/s11306-018-1412-2.


Acclimatization of low altitude-bred deer mice ( Peromyscus maniculatus) to high altitude.

Dane D, Cao K, Lu H, Yilmaz C, Dolan J, Thaler C J Appl Physiol (1985). 2018; 125(5):1411-1423.

PMID: 30091664 PMC: 6295488. DOI: 10.1152/japplphysiol.01036.2017.


Obesity and lung disease: a toxic mix.

McLoughlin P Acta Physiol (Oxf). 2015; 213(4):756-7.

PMID: 25651373 PMC: 4403963. DOI: 10.1111/apha.12462.

References
1.
Hyvelin J, Howell K, Nichol A, Costello C, Preston R, McLoughlin P . Inhibition of Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulation. Circ Res. 2005; 97(2):185-91. DOI: 10.1161/01.RES.0000174287.17953.83. View

2.
Lippl F, Neubauer S, Schipfer S, Lichter N, Tufman A, Otto B . Hypobaric hypoxia causes body weight reduction in obese subjects. Obesity (Silver Spring). 2010; 18(4):675-81. DOI: 10.1038/oby.2009.509. View

3.
ODonnell C, Tankersley C, Polotsky V, Schwartz A, Smith P . Leptin, obesity, and respiratory function. Respir Physiol. 2000; 119(2-3):163-70. DOI: 10.1016/s0034-5687(99)00111-5. View

4.
Buyse B, Markous N, Cauberghs M, van Klaveren R, Muls E, Demedts M . Effect of obesity and/or sleep apnea on chemosensitivity: differences between men and women. Respir Physiol Neurobiol. 2003; 134(1):13-22. DOI: 10.1016/s1569-9048(02)00202-1. View

5.
Watz H, Waschki B, Kirsten A, Muller K, Kretschmar G, Meyer T . The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity. Chest. 2009; 136(4):1039-1046. DOI: 10.1378/chest.09-0393. View